Results 1 to 10 of about 53,551 (201)

Iron chelating agents for iron overload diseases [PDF]

open access: yesThalassemia Reports, 2014
Although iron is an essential element for life, an excessive amount may become extremely toxic both for its ability to generate reactive oxygen species, and for the lack in humans of regulatory mechanisms for iron excretion.
Guido Crisponi   +2 more
doaj   +9 more sources

Potential of Application of Iron Chelating Agents in Ophthalmic Diseases [PDF]

open access: yesSeminars in Ophthalmology, 2021
The investigations discussed in this review indicate that iron may exacerbate different eye diseases. Therefore, it is plausible that reducing cellular or body iron stores could influence disease pathogenesis, so it is logical to consider the iron chelators' potential protective role in the various ophthalmic diseases in the form of topical eye drops ...
Joseph B Ciolino
exaly   +5 more sources

Structure of New Ferroverdins Recruiting Unconventional Ferrous Iron Chelating Agents [PDF]

open access: yesBiomolecules, 2022
Ferroverdins are ferrous iron (Fe2+)-nitrosophenolato complexes produced by a few Streptomyces species as a response to iron overload. Previously, three ferroverdins were identified: ferroverdin A, in which three molecules of p-vinylphenyl-3-nitroso-4 ...
Loïc Martinet   +3 more
doaj   +2 more sources

A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions. [PDF]

open access: yesPLoS ONE, 2015
A number of reports have appeared in literature calling attention to the depletion of essential metal ions during chelation therapy on β-thalassaemia patients.
Guido Crisponi   +6 more
doaj   +9 more sources

Amphetamine-like Deferiprone and Clioquinol Derivatives as Iron Chelating Agents [PDF]

open access: yesMolecules
The accumulation of iron in dopaminergic neurons can cause oxidative stress and dopaminergic neuron degeneration. Iron chelation therapy may reduce dopaminergic neurodegeneration, but chelators should be targeted towards dopaminergic cells. In this work,
Mahmoud El Safadi   +6 more
doaj   +2 more sources

Targeting Aging and Diseases Associated with Ferroptosis and Senescence Through Modulation of Iron, Oxidative Stress and Lipid Peroxidation [PDF]

open access: yesAntioxidants
Ferroptosis and senescence are unique cellular processes that lead to irreversible cell abnormalities and tissue damage in many diseases, such as cancer, neurodegeneration, cardiac, liver, and kidney damage.
Malamati Kourti   +1 more
doaj   +2 more sources

Iron-chelating agents for treating malaria

open access: yesThe Cochrane Library, 2003
Researchers are exploring the effects of adding treatments to the main antimalarial regimens in an attempt to reduce mortality from Plasmodium falciparum. Iron chelation is one potential chemotherapeutic adjuvant treatment. Before advocating adjunctive therapy, the effects of iron chelators in improving patient outcomes need to be examined.To assess ...
Helen Smith, Martin M Meremikwu
exaly   +6 more sources

A rapid assay for evaluation of iron-chelating agents in rats [PDF]

open access: yesBlood, 1981
Abstract The animal assay of potential new iron-chelating agents is at present dependent on cumbersome and imprecise iron balance studies in hypertransfused rodents. We report the development of a radioisotope assay in intact rats based on the transient labeling by ferritin 59Fe of the main source of chelatable iron within hepatocytes ...
Ca Finch
exaly   +4 more sources

Therapeutic potential of iron chelators in retinal vascular diseases [PDF]

open access: yesInternational Journal of Ophthalmology, 2023
Iron is one of the necessary metal elements in the human body. There are numerous factors that control the balance of iron metabolism, and its storage and transportation mechanisms are intricate.
Yan Li   +3 more
doaj   +1 more source

Role of Flavonoids in the Treatment of Iron Overload

open access: yesFrontiers in Cell and Developmental Biology, 2021
Iron overload, a high risk factor for many diseases, is seen in almost all human chronic and common diseases. Iron chelating agents are often used for treatment but, at present, most of these have a narrow scope of application, obvious side effects, and ...
Xiaomin Wang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy